This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis

This study is currently recruiting participants.
See Contacts and Locations
Verified April 2017 by Wonder Drake, Vanderbilt University
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Wonder Drake, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT02024555
First received: December 26, 2013
Last updated: June 1, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2019
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)